167 related articles for article (PubMed ID: 3456469)
1. Cell differentiation and cell cycle effects on human promyelocytic leukemia cells induced by 12-O-tetradecanoylphorbol-13-acetate.
Yun K; Sugihara H
Lab Invest; 1986 Mar; 54(3):336-44. PubMed ID: 3456469
[TBL] [Abstract][Full Text] [Related]
2. Alteration of cell cycle progression in human leukemia cell line (KOPM-28) induced by 12-o-tetradecanoylphorbol-13-acetate.
Tsuda H; Sakaguchi M; Kawakita M; Nakazawa S; Mori T; Takatsuki K
Int J Cell Cloning; 1988 May; 6(3):209-20. PubMed ID: 3397593
[TBL] [Abstract][Full Text] [Related]
3. Increased glucocorticoid receptor concentration in macrophage differentiation of myeloid leukemia cells with 12-O-tetradecanoylphorbol-13-acetate.
Hirai H; Murakami T; Urabe A; Takaku F
Cancer Res; 1985 Jun; 45(6):2456-61. PubMed ID: 3857120
[TBL] [Abstract][Full Text] [Related]
4. Early effects of the tumor-promoting phorbol ester 12-O-tetradecanoylphorbol-13-acetate on the cell cycle traverse of asynchronous HeLa cells.
Kinzel V; Richards J; Stöhr M
Cancer Res; 1981 Jan; 41(1):300-5. PubMed ID: 7448768
[TBL] [Abstract][Full Text] [Related]
5. Phorbol ester-induced differentiation of a non-T/non-B human leukemic cell line (REH) to macrophage-like cells.
Srivastava BI; Koga M; Srivastava P
Cancer Res; 1984 Jul; 44(7):3017-21. PubMed ID: 6373000
[TBL] [Abstract][Full Text] [Related]
6. Differentiation and retrodifferentiation of human myeloid leukemia cells is associated with reversible induction of cell cycle-regulatory genes.
Hass R; Gunji H; Datta R; Kharbanda S; Hartmann A; Weichselbaum R; Kufe D
Cancer Res; 1992 Mar; 52(6):1445-50. PubMed ID: 1531783
[TBL] [Abstract][Full Text] [Related]
7. Control of macrophage cell differentiation in human promyelocytic HL-60 leukemia cells by 1,25-dihydroxyvitamin D3 and phorbol-12-myristate-13-acetate.
Murao S; Gemmell MA; Callaham MF; Anderson NL; Huberman E
Cancer Res; 1983 Oct; 43(10):4989-96. PubMed ID: 6576856
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity.
Arita Y; Buffolino P; Coppock DL
Exp Cell Res; 1998 Aug; 242(2):381-90. PubMed ID: 9683525
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of human myeloid leukemia cell lines induced by tumor-promoting phorbol ester (TPA). I. Changes of the morphology, cytochemistry and the surface differentiation antigens analyzed with monoclonal antibodies.
Stöckbauer P; Malasková V; Soucek J; Chudomel V
Neoplasma; 1983; 30(3):257-72. PubMed ID: 6346116
[TBL] [Abstract][Full Text] [Related]
10. Phorbol ester effect on differentiation of human myeloid leukemia cell lines blocked at different stages of maturation.
Koeffler HP; Bar-Eli M; Territo MC
Cancer Res; 1981 Mar; 41(3):919-26. PubMed ID: 6936077
[TBL] [Abstract][Full Text] [Related]
11. Functionally deficient differentiation of HL-60 promyelocytic leukemia cells induced by phorbol myristate acetate.
Newburger PE; Baker RD; Hansen SL; Duncan RA; Greenberger JS
Cancer Res; 1981 May; 41(5):1861-5. PubMed ID: 6260353
[TBL] [Abstract][Full Text] [Related]
12. Inhibition by palmitoylcarnitine of adhesion and morphological changes in HL-60 cells induced by 12-O-tetradecanoylphorbol-13-acetate.
Nakaki T; Mita S; Yamamoto S; Nakadate T; Kato R
Cancer Res; 1984 May; 44(5):1908-12. PubMed ID: 6324991
[TBL] [Abstract][Full Text] [Related]
13. Changes in isoenzyme profiles during induction of differentiation in human myelomonocytic leukemia cell lines.
Drexler HG; Otsuka K; Gaedicke G; Minowada J
Cancer Res; 1986 Dec; 46(12 Pt 1):6078-82. PubMed ID: 2946400
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of HL-60 cells: cell volume and cell cycle changes.
Zucker RM; Whittington K; Price BJ
Cytometry; 1983 May; 3(6):414-8. PubMed ID: 6574016
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of phorbol esters on normal myeloid precursors and leukemic cells: basis for autologous bone marrow reconstitution in acute nonlymphocytic leukemia using phorbol ester-treated bone marrow from patients in remission.
Abrahm JL; Gerson SL; Hoxie JA; Tannenbaum SH; Cassileth PA; Cooper RA
Cancer Res; 1986 Jul; 46(7):3711-6. PubMed ID: 3518922
[TBL] [Abstract][Full Text] [Related]
16. Cell cycle progression and phenotypic modification of Ki67 antigen-negative G1- and G2-phase cells in phorbol ester-treated Molt-4 human leukemia cells.
Tsurusawa M; Fujimoto T
Cytometry; 1995 Jun; 20(2):146-53. PubMed ID: 7664625
[TBL] [Abstract][Full Text] [Related]
17. Modulation of cell surface antigens induced by 12-O-tetradecanoyl-phorbol 13-acetate in two myeloblastic cell lines, a promyelocytic cell line, and a monoblastic cell line: detection with five monoclonal antibodies.
Sugimoto T; Tatsumi E; Takeda K; Minato K; Sagawa K; Minowada J
J Natl Cancer Inst; 1984 Apr; 72(4):923-8. PubMed ID: 6368942
[TBL] [Abstract][Full Text] [Related]
18. Cell cycle events associated with the termination of proliferation by cytotoxic and differentiation-inducing actions of 6-thioguanine on HL-60 cells.
Schwartz EL; Blair OC; Sartorelli AC
Cancer Res; 1984 Sep; 44(9):3907-10. PubMed ID: 6589046
[TBL] [Abstract][Full Text] [Related]
19. Evidence for cell cycle phase-specific initiation of a program of HL-60 cell myeloid differentiation mediated by inducer uptake.
Yen A; Albright KL
Cancer Res; 1984 Jun; 44(6):2511-5. PubMed ID: 6327017
[TBL] [Abstract][Full Text] [Related]
20. Changes in cell surface glycoproteins and antigens during differentiation of the human myeloid leukemia cell lines ML-1, ML-2, and HL-60.
Stöckbauer P; Gahmberg CG; Andersson LC
Cancer Res; 1985 Jun; 45(6):2821-6. PubMed ID: 3857122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
